MIKAEL DOLSTEN, M.D., PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

AGILENT TECHNOLOGIES, INC.

Filing Date Source Excerpt
2022-02-03 Dr. Dolsten has significant experience in the pharmaceutical and biotechnology industries, including his experience serving in senior management positions with Wyeth Pharmaceuticals, Inc., Boehringer Ingelheim, AstraZeneca plc, Pharmacia and Upjohn Company.
2023-02-03 Dr. Dolsten has significant experience in the pharmaceutical and biotechnology industries, including his experience serving in senior management positions.
2025-01-31 Dr. Dolsten served as President of Worldwide Research, Development and Medical, Chief Scientific Officer and Executive Vice President of Pfizer, Inc. from 2010 to January 2025 and currently serves as an advisor to the CEO.

Data sourced from SEC filings. Last updated: 2026-02-03